Westfield, IN, United States of America

Joseph R Garlich


 

Average Co-Inventor Count = 3.9

ph-index = 4

Forward Citations = 68(Granted Patents)


Location History:

  • Westfield, IN (US) (2005 - 2013)
  • Hawaii National Park, HI (US) (2017 - 2018)
  • Volcano, HI (US) (2016 - 2019)
  • Fort Collins, CO (US) (2022 - 2023)

Company Filing History:


Years Active: 2005-2023

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Joseph R. Garlich: Innovator in Kinase and Checkpoint Inhibitor Research

Introduction

Joseph R. Garlich is a prominent inventor based in Westfield, Indiana, known for his significant contributions to the field of biomedical research. With a total of 11 patents to his name, Garlich has focused on developing innovative compounds and methods for treating various diseases, including cancer and autoimmune disorders. His work has the potential to impact the lives of many patients suffering from serious health conditions.

Latest Patents

Garlich's latest patents include groundbreaking inventions such as "Thienopyranones and furanopyranones as kinase, bromodomain, and checkpoint inhibitors." This invention relates to compounds and methods for treating diseases, including cancer, non-cancer proliferative diseases, sepsis, autoimmune diseases, viral infections, atherosclerosis, Type 1 or 2 diabetes, obesity, and inflammatory diseases. The invention emphasizes the modulation of biological processes by inhibiting cell cycle checkpoint targets, including CDKs and PI3 kinase. Another notable patent is "Thienopyranones and furanopyranones as checkpoint inhibitors and modulators of anti-tumor immunity." This invention also addresses various diseases and focuses on the inhibition of SYK and other proteins to enhance anti-tumor immunity.

Career Highlights

Throughout his career, Joseph R. Garlich has worked with notable companies in the pharmaceutical industry, including Signal Pharmaceuticals, Inc. and Semafore Pharmaceuticals, Inc. His experience in these organizations has allowed him to contribute to the development of innovative treatments and therapies.

Collaborations

Garlich has collaborated with esteemed colleagues in the field, including Donald L. Durden and Guillermo A. Morales. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in research.

Conclusion

Joseph R. Garlich is a distinguished inventor whose work in kinase and checkpoint inhibitor research has the potential to revolutionize treatment options for various diseases. His innovative patents and collaborations highlight his commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…